Baozun (NASDAQ:BZUN – Get Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Saturday, Wall Street Zen reports.
A number of other research analysts have also recently issued reports on BZUN. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Baozun in a report on Thursday, October 15th. CLSA raised Baozun from a “hold” rating to an “outperform” rating and upped their price objective for the company from $3.20 to $3.80 in a research report on Friday, August 28th. Finally, Citigroup restated a “buy” rating on shares of Baozun in a research note on Thursday, August 27th. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $3.80.
View Our Latest Report on Baozun
Baozun Stock Performance
BZUN opened at $3.27 on Friday. Baozun has a 12 month low of $2.07 and a 12 month high of $3.92. The business’s 50-day moving average price is $3.12 and its 200-day moving average price is $2.78. The company has a market cap of $190.12 million, a P/E ratio of -9.91 and a beta of 0.39.
Baozun (NASDAQ:BZUN – Get Free Report) last announced its quarterly earnings data on Friday, August 14th. The technology company reported $0.19 EPS for the quarter. Baozun had a negative net margin of 1.26% and a positive return on equity of 2.55%. The firm had revenue of $403.74 million during the quarter.
Baozun declared that its Board of Directors has approved a share repurchase plan on Thursday, September 24th that allows the company to buy back $10 million in shares. This buyback authorization allows the technology company to repurchase up to 4.8% of its shares through open market purchases. Share buyback plans are generally a sign that the company’s management believes its stock is undervalued.
Insiders Place Their Bets
In other Baozun news, insider Junhua Wu bought 13,900 shares of Baozun stock in a transaction on Tuesday, September 15th. The shares were purchased at an average price of $2.73 per share, with a total value of $37,947.00. Following the acquisition, the insider owned 281,170 shares in the company, valued at $767,594.10. This trade represents a 5.20% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders have purchased a total of 80,500 shares of company stock valued at $236,531 over the last 90 days. Insiders own 59.20% of the company’s stock.
Institutional Trading of Baozun
An institutional investor recently raised its position in Baozun stock. Cetera Investment Advisers grew its position in Baozun Inc. (NASDAQ:BZUN – Free Report) by 23.6% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 38,238 shares of the technology company’s stock after purchasing an additional 7,289 shares during the quarter. Cetera Investment Advisers owned about 0.07% of Baozun worth $91,000 as of its most recent SEC filing. Institutional investors and hedge funds own 47.29% of the company’s stock.
About Baozun
Baozun Inc (NASDAQ: BZUN) is a China-based e-commerce services company that helps domestic and international brands establish, operate and grow their online businesses. The company provides an integrated suite of services covering digital storefront development, online sales operations, digital marketing, customer service, warehousing and logistics.
Baozun supports brands across major Chinese e-commerce platforms and other digital channels. Its services may be delivered through different operating models, including technology and service arrangements, distribution and online retail solutions.
Featured Stories
- Five stocks we like better than Baozun
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Baozun Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baozun and related companies with MarketBeat.com's FREE daily email newsletter.
